+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hepatitis E Diagnostic Tests Market (2022-2027) by Disease Type, Technology, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 178 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5669468

According to WHO, Every year there are an estimated 20 Mn HEV infections worldwide, leading to an estimated 3.3 Mn symptomatic cases of Hepatitis E

The Global Hepatitis E Diagnostic Tests Market is estimated to be USD 71.06 Mn in 2022 and is expected to reach USD 100.6 Mn by 2027, growing at a CAGR of 7.2%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Market Segmentations

The Global Hepatitis E Diagnostic Tests Market is segmented based on Disease Type, Technology, and Geography.
  • By Disease Type, the market is classified into Hepatitis B (HBV) and Hepatitis C (HCV).
  • By Technology, the market is classified into Enzyme-linked Immunosorbent Assay (ELISA), Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerase Chain Reaction (PCR), and Rapid Diagnostic Tests (RDT).
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, altona Diagnostics GmbH, Bio-Rad Laboratories Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Fortress Diagnostics Ltd., Fujirebio Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Hepatitis E Diagnostic Tests Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Hepatitis E Diagnostic Tests Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Hepatitis E Diagnostic Tests Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Hepatitis E Diagnostic Tests Market

What is the estimated value of the Global Hepatitis E Diagnostic Tests Market?

The Global Hepatitis E Diagnostic Tests Market was estimated to be valued at $71.06 Million in 2022.

What is the growth rate of the Global Hepatitis E Diagnostic Tests Market?

The growth rate of the Global Hepatitis E Diagnostic Tests Market is 7.2%, with an estimated value of $100.6 Million by 2027.

What is the forecasted size of the Global Hepatitis E Diagnostic Tests Market?

The Global Hepatitis E Diagnostic Tests Market is estimated to be worth $100.6 Million by 2027.

Who are the key companies in the Global Hepatitis E Diagnostic Tests Market?

Key companies in the Global Hepatitis E Diagnostic Tests Market include Abbott Laboratories, altona Diagnostics GmbH, Bio, Rad Laboratories, Inc., bioMérieux SA, F. Hoffmann, La Roche, Ltd., Fortress Diagnostics, Ltd., Fujirebio, Inc. and Grifols S.A..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Prevalence of Hepatitis and Increasing Geriatric Population
4.1.2 Changing Lifestyle and Food Consumption Habit and Excessive Consumption of Alcohol
4.1.3 Increasing Awareness About Hepatitis by Government and Non-profit Organization
4.2 Restraints
4.2.1 Side-Effects of Medication
4.2.2 Complexities in Testing and Diagnosis
4.3 Opportunities
4.3.1 Rising Technological Advancements and Modernization in the Healthcare Sector
4.3.2 Increase in Regulatory Approvals, and Growing Participation of Generic Drugs Manufacturers
4.4 Challenges
4.4.1 Lack of Authoritative Directive Regarding the Testing for Hepatitis Virus
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Hepatitis E Diagnostic Tests Market, By Disease Type
6.1 Introduction
6.2 Hepatitis B (HBV)
6.3 Hepatitis C (HCV)
7 Global Hepatitis E Diagnostic Tests Market, By Technology
7.1 Introduction
7.2 Enzyme-linked Immunosorbent Assay (ELISA)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Polymerase Chain Reaction (PCR)
7.5 Rapid Diagnostic Tests (RDT)
8 Americas’ Hepatitis E Diagnostic Tests Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Hepatitis E Diagnostic Tests Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Hepatitis E Diagnostic Tests Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Hepatitis E Diagnostic Tests Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 altona Diagnostics GmbH
13.3 Bio-Rad Laboratories, Inc.
13.4 bioMérieux SA
13.5 F. Hoffmann-La Roche, Ltd.
13.6 Fortress Diagnostics, Ltd.
13.7 Fujirebio, Inc.
13.8 Grifols S.A.
13.9 Primerdesign, Ltd.
13.10 Mikrogen GmBH
13.11 QIAGEN
13.12 Quest Diagnostics, Inc.
13.13 Siemens Ag
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • altona Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Fortress Diagnostics, Ltd.
  • Fujirebio, Inc.
  • Grifols S.A.
  • Primerdesign, Ltd.
  • Mikrogen GmBH
  • Quest Diagnostics, Inc.
  • Siemens Ag